Wuxi Biologics (Cayman)'s total assets for Q2 2022 were ¥47.47B, an increase of 7.81% from the previous quarter. WXIBF total liabilities were ¥― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.